🇺🇸 FDA
Patent

US 12128034

Combinations of beta-lactam compounds, probenecid, and valproic acid and uses thereof

granted A61KA61K31/18A61K31/19

Quick answer

US patent 12128034 (Combinations of beta-lactam compounds, probenecid, and valproic acid and uses thereof) held by Iterum Therapeutics International Limited expires Mon Oct 24 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Iterum Therapeutics International Limited
Grant date
Tue Oct 29 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 24 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K31/18, A61K31/19, A61K31/245, A61K31/431